These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 28843356)

  • 21. Oral budesonide for induction of remission in ulcerative colitis.
    Sherlock ME; Seow CH; Steinhart AH; Griffiths AM
    Cochrane Database Syst Rev; 2010 Oct; (10):CD007698. PubMed ID: 20927762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association Between Response to Etrolizumab and Expression of Integrin αE and Granzyme A in Colon Biopsies of Patients With Ulcerative Colitis.
    Tew GW; Hackney JA; Gibbons D; Lamb CA; Luca D; Egen JG; Diehl L; Eastham Anderson J; Vermeire S; Mansfield JC; Feagan BG; Panes J; Baumgart DC; Schreiber S; Dotan I; Sandborn WJ; Kirby JA; Irving PM; De Hertogh G; Van Assche GA; Rutgeerts P; O'Byrne S; Hayday A; Keir ME
    Gastroenterology; 2016 Feb; 150(2):477-87.e9. PubMed ID: 26522261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis.
    Lawson MM; Thomas AG; Akobeng AK
    Cochrane Database Syst Rev; 2006 Jul; (3):CD005112. PubMed ID: 16856078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic Review and Meta-Analysis: Clinical, Endoscopic, Histological and Safety Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis.
    Sedano R; Hogan M; Nguyen TM; Chang J; Zou GY; Macdonald JK; Vande Casteele N; Hanzel J; Crowley E; Battat R; Dulai PS; Singh S; D'Haens G; Sandborn W; Feagan BG; Ma C; Jairath V
    J Crohns Colitis; 2022 Feb; 16(2):224-243. PubMed ID: 34309658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease.
    ; Ma C; Hanzel J; Panaccione R; Sandborn WJ; D'Haens GR; Ahuja V; Atreya R; Bernstein CN; Bossuyt P; Bressler B; Bryant RV; Cohen B; Colombel JF; Danese S; Dignass A; Dubinsky MC; Fleshner PR; Gearry RB; Hanauer SB; Hart A; Kotze PG; Kucharzik T; Lakatos PL; Leong RW; Magro F; Panés J; Peyrin-Biroulet L; Ran Z; Regueiro M; Singh S; Spinelli A; Steinhart AH; Travis SP; van der Woude CJ; Yacyshyn B; Yamamoto T; Allez M; Bemelman WA; Lightner AL; Louis E; Rubin DT; Scherl EJ; Siegel CA; Silverberg MS; Vermeire S; Parker CE; McFarlane SC; Guizzetti L; Smith MI; Vande Casteele N; Feagan BG; Jairath V
    Gastroenterology; 2022 Oct; 163(4):950-964. PubMed ID: 35788348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consistent efficacy outcomes between phase 2 and phase 3 trials in Crohn's disease or ulcerative colitis in adults: a meta-analysis.
    Wan Z; Jiang Q; Zhou R; Li X; Han W; Xu B; Guo M; Ruan G; Bai X; Li G; Yang H
    Inflamm Res; 2024 Jun; 73(6):915-928. PubMed ID: 38587530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical, Endoscopic and Histological Outcomes in Induction of Moderate-to-Severe Ulcerative Colitis: A Systematic Review with Meta-Analysis.
    Magro F; Estevinho MM; Dias CC; Correia L; Lago P; Ministro P; Portela F; Feakins R; Danese S; Peyrin-Biroulet L
    J Crohns Colitis; 2021 Apr; 15(4):551-566. PubMed ID: 32898223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-Term Benefit of Mesalamine Granules for Patients Who Achieved Corticosteroid-Induced Ulcerative Colitis Remission.
    Lichtenstein GR; Gordon GL; Zakko S; Murthy U; Sedghi S; Pruitt R; Barrett AC; Bortey E; Paterson C; Forbes WP
    Dig Dis Sci; 2016 Jan; 61(1):221-9. PubMed ID: 26563167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histological Remission Placebo Rates in Ulcerative Colitis Trials: A Systematic Review and Meta-analysis.
    Youssef M; Dong K; Lee SJ; Narula N
    Inflamm Bowel Dis; 2024 Jan; 30(1):125-131. PubMed ID: 36753516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus.
    Vuitton L; Peyrin-Biroulet L; Colombel JF; Pariente B; Pineton de Chambrun G; Walsh AJ; Panes J; Travis SP; Mary JY; Marteau P
    Aliment Pharmacol Ther; 2017 Mar; 45(6):801-813. PubMed ID: 28112419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies.
    Sandborn WJ; Danese S; D'Haens G; Moro L; Jones R; Bagin R; Huang M; David Ballard E; Masure J; Travis S
    Aliment Pharmacol Ther; 2015 Mar; 41(5):409-18. PubMed ID: 25588902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis.
    Costello SP; Soo W; Bryant RV; Jairath V; Hart AL; Andrews JM
    Aliment Pharmacol Ther; 2017 Aug; 46(3):213-224. PubMed ID: 28612983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methotrexate Is Not Superior to Placebo in Maintaining Steroid-Free Response or Remission in Ulcerative Colitis.
    Herfarth H; Barnes EL; Valentine JF; Hanson J; Higgins PDR; Isaacs KL; Jackson S; Osterman MT; Anton K; Ivanova A; Long MD; Martin C; Sandler RS; Abraham B; Cross RK; Dryden G; Fischer M; Harlan W; Levy C; McCabe R; Polyak S; Saha S; Williams E; Yajnik V; Serrano J; Sands BE; Lewis JD;
    Gastroenterology; 2018 Oct; 155(4):1098-1108.e9. PubMed ID: 29964043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Impact of Raising the Bar for Clinical Trials in Ulcerative Colitis.
    Sands BE; Cheifetz AS; Nduaka CI; Quirk D; Wang W; Maller E; Friedman GS; Su C; Higgins PDR
    J Crohns Colitis; 2019 Sep; 13(9):1217-1226. PubMed ID: 30879034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transdermal nicotine for induction of remission in ulcerative colitis.
    McGrath J; McDonald JW; Macdonald JK
    Cochrane Database Syst Rev; 2004 Oct; (4):CD004722. PubMed ID: 15495126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclosporine A for induction of remission in severe ulcerative colitis.
    Shibolet O; Regushevskaya E; Brezis M; Soares-Weiser K
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004277. PubMed ID: 15674937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis.
    Narula N; Kassam Z; Yuan Y; Colombel JF; Ponsioen C; Reinisch W; Moayyedi P
    Inflamm Bowel Dis; 2017 Oct; 23(10):1702-1709. PubMed ID: 28906291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis.
    Naganuma M; Sugimoto S; Mitsuyama K; Kobayashi T; Yoshimura N; Ohi H; Tanaka S; Andoh A; Ohmiya N; Saigusa K; Yamamoto T; Morohoshi Y; Ichikawa H; Matsuoka K; Hisamatsu T; Watanabe K; Mizuno S; Suda W; Hattori M; Fukuda S; Hirayama A; Abe T; Watanabe M; Hibi T; Suzuki Y; Kanai T;
    Gastroenterology; 2018 Mar; 154(4):935-947. PubMed ID: 29174928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and Safety of Adalimumab in Moderately to Severely Active Cases of Ulcerative Colitis: A Meta-Analysis of Published Placebo-Controlled Trials.
    Zhang ZM; Li W; Jiang XL
    Gut Liver; 2016 Mar; 10(2):262-74. PubMed ID: 26780088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial.
    Moayyedi P; Surette MG; Kim PT; Libertucci J; Wolfe M; Onischi C; Armstrong D; Marshall JK; Kassam Z; Reinisch W; Lee CH
    Gastroenterology; 2015 Jul; 149(1):102-109.e6. PubMed ID: 25857665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.